Lymphoma Clinical Trials
Lymphoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for lymphoma. Corterve aggregates actively recruiting Lymphoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Lymphoma studies
- Personalized NK Cell Therapy in CBTNCT02727803PHASE2M.D. Anderson Cancer CenterHouston, Texas
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer TreatmentNCT01087333National Cancer Institute (NCI)Bethesda, Maryland
- Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell LymphomaNCT03223610PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaNCT05645107PHASE3Grifols Therapeutics LLCHuntington Park, California
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerNCT00006518National Cancer Institute (NCI)Bethesda, Maryland
- Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaNCT06337318PHASE3National Cancer Institute (NCI)Birmingham, Alabama
- First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.NCT07586618PHASE1Allterum Therapeutics, IncAurora, Colorado
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsNCT02682667National Cancer Institute (NCI)Bethesda, Maryland
- A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell LymphomasNCT05773040PHASE1M.D. Anderson Cancer CenterHouston, Texas
- Tissue Collection for Studies of Lymph CancerNCT01676805National Cancer Institute (NCI)Bethesda, Maryland
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)NCT07634471PHASE2, PHASE3Merck Sharp & Dohme LLCNashville, Tennessee
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)NCT06943872PHASE3BeOne MedicinesLaguna Hills, California
Lymphoma trials by state
Lymphoma trials by metro
Frequently asked questions
- How do I find recruiting Lymphoma clinical trials?
- Corterve aggregates actively recruiting Lymphoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Lymphoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Lymphoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.